HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New REACH Rules Will Reduce Animal Use For Assessing Sensitization, Other Endpoints

This article was originally published in The Rose Sheet

Executive Summary

Alternative testing methods addressing key events in the OECD's adverse outcome pathway for skin sensitization may be sufficient to fulfill REACH data needs under a new rule slated for implementation later this year. Another pending change is expected to reduce firms' dependence on animal tests to evaluate skin and eye irritation and acute toxicity as the final REACH deadline for phase-in substances draws closer.

Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS019930

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel